Featured Research

from universities, journals, and other organizations

'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban

Date:
March 16, 2011
Source:
BMJ-British Medical Journal
Summary:
A new legal high has emerged that seems to be replacing the banned substance mephedrone or "miaow miaow," warns a critical care paramedic in a new article.

A new legal high has emerged that seems to be replacing the banned substance mephedrone or "miaow miaow," warns a critical care paramedic in Emergency Medicine Journal.

Related Articles


Mephedrone was banned in England, when it was reclassified as a class B drug in April 2010.

The new drug in circulation is "ivory wave," also known as "purple wave," "ivory coast," or "vanilla sky." And its use has already been implicated in hospital admissions and deaths in various parts of England, says the author.

Ivory wave is usually sold online as bath salts in packets of between 200 and 500 mg, for £15 a pop. It can be snorted or swallowed.

"Whether or not this drug in fact contains illegal ingredients is as yet unclear," writes the author from the Southeast Coast Ambulance Service. "The drug's effects are concerning, however, and have been seen in patients in Lothian, Cumbria, Dorset and Essex."

The author describes in detail a case of ivory wave intoxication in a bid to raise awareness of a "drug which seems to be rapidly gaining popularity, " he says.

The case in question was a young man who had been detained in a police custody suite where he complained of sudden rapid heartbeat and chest pain. He was extremely agitated and anxious, hallucinating, and subject to involuntary facial contortions.

He was breathing very rapidly and had high blood pressure. He was given a drug normally used to treat episodes of angina and an anti-anxiety drug, in the belief that he had snorted coke.

This calmed him down, after which he admitted that he had snorted 2 g of ivory wave earlier that day.

Ivory wave can contain the stimulant methylenedioxypyrovalerone (MDPV) and the anaesthetic lignocaine, analysis has shown. But there doesn't seem to be any "set" recipe, says the author, so it can vary enormously in content. MDPV can have effects in doses as low as 5 mg.

Ivory wave's reported effects include initial euphoria, with other symptoms occurring up to a day after using, and lasting as long as a week.

These include overstimulation of the nervous and cardiovascular systems, resulting in acute paranoid psychosis, with extreme agitation, insomnia, dizziness, hyperthermia, and fitting, chest pains and variations in blood pressure that can damage the kidneys.

In some cases, the resulting agitation and paranoia have prompted patients to assault hospital staff, writes the author.

"It seems quite plausible that this drug could be the 'next mephedone'," suggests the author. "Reports reveal that its popularity has been [growing] and its use spreading across the UK in recent months."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Durham. Ivory wave: the next mephedrone? Emergency Medicine Journal, 2011; DOI: 10.1136/emj.2011.112920

Cite This Page:

BMJ-British Medical Journal. "'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban." ScienceDaily. ScienceDaily, 16 March 2011. <www.sciencedaily.com/releases/2011/03/110314184712.htm>.
BMJ-British Medical Journal. (2011, March 16). 'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2011/03/110314184712.htm
BMJ-British Medical Journal. "'Ivory wave' may be new legal high after 'miaow miaow' (mephedrone) ban." ScienceDaily. www.sciencedaily.com/releases/2011/03/110314184712.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins